DaVita healthCare Partners Inc Stock News

DENVER , May 14, 2024 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a n

Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita  DENVER , May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announ

Investors target stocks that have lately been on a bull run. Stocks like HAS, EAT, DVA, LDOS and ALL are seeing price strength and have a high chance of carrying the momentum forward.

DaVita (DVA), Minerals Technologies (MTX), Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.

DENVER , May 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER , May 9, 2024 /PRNewswir

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised

Here is how DaVita HealthCare (DVA) and Alcon (ALC) have performed compared to their sector so far this year.

We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ROOT, SMCI, PPC, DFH and DVA have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2024.

DFH, DVA and BDC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 6, 2024.